MERGE's Pat McGloin on why pharma AI fails when strategy follows technology — and why the brilliant basics still have to come first.
News|Articles|September 1, 2026
Accelerating patient recruitment: Connecting the right patients to the right trial
Author(s)Quest Diagnostics
Advertisement
Discover how Quest Diagnostics puts its vast database of lab results to work and leverages patient and physician credibility to efficiently and effectively connect the best-fit patients to the clinical trials that will benefit from their participation.
This white paper is free and can be downloaded and read at your convenience.
Advertisement
Related to this article
Exploring the emergence of agentic ecosystems in transforming data accessibility and ensuring reliable answers reach the people making decisions while there is still a choice to make.
Advertisement
Advertisement
Trending on PharmExec
1
Merck KGaA, Darmstadt, Germany, Acquires Silence Therapeutics for $1.3 Billion
2
Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche
3
Is Participation in MFN Voluntary?
4
The Bubble You Don’t Know You’re In: A Three-Part Series on The Medical Benefit Bubble
5